|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CARDIAC SCIENCE INC, 10-Q, 2000-11-14 |
Next: BIOTIME INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED CONDENSED BALANCE SHEET AS OF SEPTEMBER 30, 2000 AND THE
UNAUDITED CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS FOR THE NINE MONTHS
ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 25,176,207
<SECURITIES> 0
<RECEIVABLES> 1,500,721
<ALLOWANCES> 0
<INVENTORY> 2,430,061
<CURRENT-ASSETS> 29,261,311
<PP&E> 2,053,186
<DEPRECIATION> 601,626
<TOTAL-ASSETS> 39,381,297
<CURRENT-LIABILITIES> 4,822,225
<BONDS> 0
24,145
0
<COMMON> 0
<OTHER-SE> 34,308,564
<TOTAL-LIABILITY-AND-EQUITY> 39,381,297
<SALES> 2,759,286
<TOTAL-REVENUES> 2,759,286
<CGS> 2,452,693
<TOTAL-COSTS> 26,204,227
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (388,642)
<INCOME-PRETAX> (25,558,992)
<INCOME-TAX> 1,600
<INCOME-CONTINUING> (25,560,592)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (25,560,592)
<EPS-BASIC> (1.47)
<EPS-DILUTED> (1.47)
</TABLE>
|
|